Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Accepted author manuscript, 2.78 MB, PDF document
| Original language | English |
|---|---|
| Journal | International Journal of Cancer |
| Volume | 147 |
| Issue number | 5 |
| Pages (from-to) | 1315-1324 |
| Number of pages | 10 |
| ISSN | 0020-7136 |
| DOIs | |
| Publication status | Published - 2020 |
- chronic lymphocytic leukemia, circulating miRNA, serum, prospective study
Research areas
ID: 237410427